Authors:
IBEANU GC
BLAISDELL J
GHANAYEM BI
BEYELER C
BENHAMOU S
BOUCHARDY C
WILKINSON GR
DAYER P
DALY AK
GOLDSTEIN JA
Citation: Gc. Ibeanu et al., AN ADDITIONAL DEFECTIVE ALLELE, CYP2C19-ASTERISK-5, CONTRIBUTES TO THE S-MEPHENYTOIN POOR METABOLIZER PHENOTYPE IN CAUCASIANS, Pharmacogenetics, 8(2), 1998, pp. 129-135
Authors:
BHAGAVAN NV
GOLDSTEIN AP
HONDA SAA
UYEHARA J
BLAISDELL J
SUGIYAMA C
MURAKAMI L
KANG L
FUJITANI G
Citation: Nv. Bhagavan et al., ROLE OF CARDIAC TROPONIN-I IN THE EVALUATION OF MYOCARDIAL INJURY, Journal of clinical laboratory analysis, 12(5), 1998, pp. 276-279
Citation: J. Blaisdell et al., ISOLATION OF A NEW CANINE CYTOCHROME-P450 CDNA FROM THE CYTOCHROME-P450 2C SUBFAMILY (CYP2C41) AND EVIDENCE FOR POLYMORPHIC DIFFERENCES IN ITS EXPRESSION, Drug metabolism and disposition, 26(3), 1998, pp. 278-283
Authors:
BORER JG
ATALA A
PARK JM
ADAM RM
BLAISDELL J
GUTHRIE PD
RETIK AB
FREEMAN MR
Citation: Jg. Borer et al., HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR EXPRESSION IS UP-REGULATED IN BLADDER INFLAMMATION, Pediatrics (Evanston), 102(3), 1998, pp. 862-862
Authors:
IBEANU GC
GOLDSTEIN JA
MEYER U
BENHAMOU S
BOUCHARDY C
DAYER P
GHANAYEM BI
BLAISDELL J
Citation: Gc. Ibeanu et al., IDENTIFICATION OF NEW HUMAN CYP2C19 ALLELES (CYP2C19-ASTERISK-6 AND CYP2C19-ASTERISK-2B) IN A CAUCASIAN POOR METABOLIZER OF MEPHENYTOIN, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1490-1495
Authors:
FERGUSON RJ
DEMORAIS SMF
BENHAMOU S
BOUCHARDY C
BLAISDELL J
IBEANU G
WILKINSON GR
SARICH TC
WRIGHT JM
DAYER P
GOLDSTEIN JA
Citation: Rj. Ferguson et al., A NEW GENETIC-DEFECT IN HUMAN CYP2C19 - MUTATION OF THE INITIATION CODON IS RESPONSIBLE FOR POOR METABOLISM OF S-MEPHENYTOIN, The Journal of pharmacology and experimental therapeutics, 284(1), 1998, pp. 356-361
Authors:
XIAO ZS
GOLDSTEIN JA
XIE HG
BLAISDELL J
WANG W
JIANG CH
YAN FX
HE N
HUANG SL
XU ZH
ZHOU HH
Citation: Zs. Xiao et al., DIFFERENCES IN THE INCIDENCE OF THE CYP2C19 POLYMORPHISM AFFECTING THE S-MEPHENYTOIN PHENOTYPE IN CHINESE HAN AND BAI POPULATIONS AND IDENTIFICATION OF A NEW RARE CYP2C19 MUTANT ALLELE, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 604-609
Authors:
PETROVITCH H
HARDMAN J
ROSS W
BLAISDELL J
MASAKI K
WHITE L
Citation: H. Petrovitch et al., ANKLE-ARM DIFFERENCE IN BLOOD-PRESSURE AND SERUM-CHOLESTEROL LEVEL ARE POTENT PREDICTORS OF STROKES IN AN AUTOPSY SERIES OF OLDER JAPANESE-AMERICAN MEN, Neurology, 45(4), 1995, pp. 459-459
Authors:
ROSS GW
HARDMAN J
PETROVITCH H
MASAKI K
BLAISDELL J
TERASHITA S
WHITE L
Citation: Gw. Ross et al., CEREBROVASCULAR-DISEASE IN AN UNSELECTED AUTOPSY SERIES OF ELDERLY JAPANESE-AMERICAN MEN, Neurology, 45(4), 1995, pp. 460-460
Authors:
DEMORAIS SMF
WILKINSON GR
BLAISDELL J
MEYER UA
NAKAMURA K
GOLDSTEIN JA
Citation: Smf. Demorais et al., IDENTIFICATION OF A NEW GENETIC-DEFECT RESPONSIBLE FOR THE POLYMORPHISM OF (S)-MEPHENYTOIN METABOLISM IN JAPANESE, Molecular pharmacology, 46(4), 1994, pp. 594-598
Authors:
DEMORAIS SMF
WILKINSON GR
BLAISDELL J
NAKAMURA K
MEYER UA
GOLDSTEIN JA
Citation: Smf. Demorais et al., THE MAJOR GENETIC-DEFECT RESPONSIBLE FOR THE POLYMORPHISM OF S-MEPHENYTOIN METABOLISM IN HUMANS, The Journal of biological chemistry, 269(22), 1994, pp. 15419-15422
Authors:
DEMORAIS SMF
SCHWEIKL H
BLAISDELL J
GOLDSTEIN JA
Citation: Smf. Demorais et al., GENE STRUCTURE AND REGULATORY UPSTREAM REGIONS OF 2 HUMAN CYTOCHROMES-P4502C (2C9 AND 2C18) ASSOCIATED WITH S-MEPHENYTOIN HYDROXYLATION, The FASEB journal, 7(7), 1993, pp. 1167-1167
Authors:
DEMORAIS SMF
SCHWEIKL H
BLAISDELL J
GOLDSTEIN JA
Citation: Smf. Demorais et al., GENE STRUCTURE AND UPSTREAM REGULATORY REGIONS OF HUMAN CYP2C9 AND CYP2C18, Biochemical and biophysical research communications, 194(1), 1993, pp. 194-201